⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for vancomycin

Every month we try and update this database with for vancomycin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-respondersNCT04729322
Metastatic Colo...
Metastatic Smal...
Stage IV Colore...
Stage IV Small ...
Stage IVA Color...
Stage IVB Color...
Stage IVC Color...
Biopsy
Fecal Microbiot...
Fecal Microbiot...
Metronidazole
Neomycin
Nivolumab
Pembrolizumab
Questionnaire A...
Vancomycin
18 Years - M.D. Anderson Cancer Center
PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONINNCT04983901
Hematopoietic a...
Malignant Solid...
Imipenem/Cilast...
Cefepime
Meropenem
Piperacillin-Ta...
Vancomycin
Daptomycin
Linezolid
18 Years - M.D. Anderson Cancer Center
Randomized Pilot Trial of Antimicrobial Therapy and Stereotactic Body Radiation Therapy in Early-stage Non-small Cell Lung CancerNCT03546829
Early Stage Non...
Vancomycin
Stereotactic Bo...
18 Years - Abramson Cancer Center at Penn Medicine
Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive InfectionNCT00035425
Febrile Neutrop...
linezolid
vancomycin
13 Years - Pfizer
Optimal Dosing of Vancomycin in an Adult Population of Hemato-oncologyNCT04758442
Vancomycin
Hematologic Mal...
Febrile Neutrop...
Additional bloo...
18 Years - Ciusss de L'Est de l'Île de Montréal
Randomized Pilot Trial of Antimicrobial Therapy and Stereotactic Body Radiation Therapy in Early-stage Non-small Cell Lung CancerNCT03546829
Early Stage Non...
Vancomycin
Stereotactic Bo...
18 Years - Abramson Cancer Center at Penn Medicine
PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONINNCT04983901
Hematopoietic a...
Malignant Solid...
Imipenem/Cilast...
Cefepime
Meropenem
Piperacillin-Ta...
Vancomycin
Daptomycin
Linezolid
18 Years - M.D. Anderson Cancer Center
Daptomycin or Vancomycin in Treating Bacteria in the Blood in Patients With Neutropenia Caused By ChemotherapyNCT00296049
Infection
Neutropenia
Unspecified Adu...
Unspecified Chi...
daptomycin
vancomycin
- 120 YearsWake Forest University Health Sciences
Vancomycin in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLC) OralNCT04025567
Metastatic Hepa...
Hepatocellular ...
vancomycin
18 Years - National Institutes of Health Clinical Center (CC)
Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology PatientsNCT03030248
Clostridium Dif...
Hematologic Dis...
Bone Marrow Tra...
Oncologic Disor...
Vancomycin Oral...
Placebo Oral Ca...
18 Years - Medical College of Wisconsin
PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONINNCT04983901
Hematopoietic a...
Malignant Solid...
Imipenem/Cilast...
Cefepime
Meropenem
Piperacillin-Ta...
Vancomycin
Daptomycin
Linezolid
18 Years - M.D. Anderson Cancer Center
Randomized Pilot Trial of Antimicrobial Therapy and Stereotactic Body Radiation Therapy in Early-stage Non-small Cell Lung CancerNCT03546829
Early Stage Non...
Vancomycin
Stereotactic Bo...
18 Years - Abramson Cancer Center at Penn Medicine
PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONINNCT04983901
Hematopoietic a...
Malignant Solid...
Imipenem/Cilast...
Cefepime
Meropenem
Piperacillin-Ta...
Vancomycin
Daptomycin
Linezolid
18 Years - M.D. Anderson Cancer Center
Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-respondersNCT04729322
Metastatic Colo...
Metastatic Smal...
Stage IV Colore...
Stage IV Small ...
Stage IVA Color...
Stage IVB Color...
Stage IVC Color...
Biopsy
Fecal Microbiot...
Fecal Microbiot...
Metronidazole
Neomycin
Nivolumab
Pembrolizumab
Questionnaire A...
Vancomycin
18 Years - M.D. Anderson Cancer Center
Vancomycin in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLC) OralNCT04025567
Metastatic Hepa...
Hepatocellular ...
vancomycin
18 Years - National Institutes of Health Clinical Center (CC)
Comparison of Teicoplanin and Vancomycin in Initial Empirical Antibiotic Regimen for Febrile Neutropenic PatientsNCT00454272
Infection
Febrile Neutrop...
Teicoplanin
Vancomycin
2 Years - Sanofi
Optimal Dosing of Vancomycin in an Adult Population of Hemato-oncologyNCT04758442
Vancomycin
Hematologic Mal...
Febrile Neutrop...
Additional bloo...
18 Years - Ciusss de L'Est de l'Île de Montréal
Daptomycin or Vancomycin in Treating Bacteria in the Blood in Patients With Neutropenia Caused By ChemotherapyNCT00296049
Infection
Neutropenia
Unspecified Adu...
Unspecified Chi...
daptomycin
vancomycin
- 120 YearsWake Forest University Health Sciences
Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-respondersNCT04729322
Metastatic Colo...
Metastatic Smal...
Stage IV Colore...
Stage IV Small ...
Stage IVA Color...
Stage IVB Color...
Stage IVC Color...
Biopsy
Fecal Microbiot...
Fecal Microbiot...
Metronidazole
Neomycin
Nivolumab
Pembrolizumab
Questionnaire A...
Vancomycin
18 Years - M.D. Anderson Cancer Center
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: